Charlottesvle, Virginia (VA) Pharmaceuticals Companies

Featured companies
Adenosine Therapeutics
310 4th St NE # 201
Charlottesville VA 22902
(434) 220-9400
MVA Consulting Inc
2120 Masseys Wood Rd.
Charlottesville VA 22903
(434) 972-9800
CVS Pharmacy
208 E Main St.
Charlottesville VA 22902
(434) 293-6052
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Timberlake's Drug Store
322 E Main St.
Charlottesville VA 22902
(434) 295-9155
CVS Pharmacy
1133 5th St SW
Charlottesville VA 22902
(434) 979-1441
Cardinal Health
713 Harris St.
Charlottesville VA 22903
(434) 295-7069
Diffusion Pharmaceuticals LLC
2020 Avon Ct # 4
Charlottesville VA 22902
(434) 220-0718
CVS Pharmacy
1137 Emmet St N
Charlottesville VA 22903
(434) 293-5346
Marshall Pharmacies Inc
425 Lexington Ave.
Charlottesville VA 22902
(434) 293-8111
Cardinal Health
713b Harris St.
Charlottesville VA 22903
(434) 984-1225
Afton Scientific Corp
2030 Avon Ct
Charlottesville VA 22902
(434) 979-3737
Whereorg has 13 results under Pharmaceuticals Companies in Charlottesvle.

Narrow down the browsing criteria below to see more companies.

Select a category for location Charlottesvle, Virginia

Select a location for category Pharmaceuticals

Quick navigation
All industries Pharmaceuticals
All states Virginia Charlottesvle
City or suburb

Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020